Dr. William G. Blum
Claim this profileEmory University
Studies Leukemia
Studies Acute Myeloid Leukemia
13 reported clinical trials
38 drugs studied
Area of expertise
1Leukemia
CD22 positive
Philadelphia chromosome/BCR-ABL1 negative
CD20 positive
2Acute Myeloid Leukemia
LILRB4 positive
FLT3 positive
LILRB4 negative
Affiliated Hospitals
Clinical Trials William G. Blum is currently running
HMPL-306
for Blood Cancers
An open label single-arm clinical trial to evaluate the safety, tolerability, PK, PD, and preliminary efficacy of HMPL-306 in subjects with advanced relapsed, refractory, or resistant hematological malignancies that harbor IDH mutations.
Recruiting1 award Phase 13 criteria
Inotuzumab Ozogamicin + Chemotherapy
for Leukemia and Lymphoma
This trial tests a new treatment combining inotuzumab ozogamicin with chemotherapy for patients with certain types of blood cancer. The new drug targets cancer cells directly and delivers a toxin to kill them. This approach aims to improve the effectiveness of treatment compared to standard chemotherapy alone. Inotuzumab ozogamicin has shown superior efficacy compared to conventional chemotherapy in patients with specific types of blood cancer.
Recruiting3 awards Phase 2
More about William G. Blum
Clinical Trial Related3 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments William G. Blum has experience with
- Inotuzumab Ozogamicin
- Venetoclax
- Cytarabine
- Azacitidine
- Doxorubicin
- Entospletinib
Breakdown of trials William G. Blum has run
Leukemia
Acute Myeloid Leukemia
Myeloid Leukemia
Lymphoblastic Leukemia-Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William G. Blum specialize in?
William G. Blum focuses on Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Leukemia has involved CD22 positive patients, or patients who are Philadelphia chromosome/BCR-ABL1 negative.
Is William G. Blum currently recruiting for clinical trials?
Yes, William G. Blum is currently recruiting for 7 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that William G. Blum has studied deeply?
Yes, William G. Blum has studied treatments such as Inotuzumab Ozogamicin, Venetoclax, Cytarabine.
What is the best way to schedule an appointment with William G. Blum?
Apply for one of the trials that William G. Blum is conducting.
What is the office address of William G. Blum?
The office of William G. Blum is located at: Emory University, Atlanta, Georgia 30308 United States. This is the address for their practice at the Emory University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.